would love to meet managmeent if they come to sydney, i hold...

First 7 Last

Share
Profile

Follow
Rx7driftking

7,797 Posts.

19

30/05/17

22:56

Post #: 25003413
Share

Originally posted by christophe ↑

The chances of price sensitive news coming soon for BDA are many and from various areas.

As far as the medicinal cannabis is concerned I'm particularly interested in seeing what happens in these 3 areas during the month of June.

Skincare – Nioskin
This is available to import immediately. Base products currently exist under the Nioskin™ brand including a serum, facial mist and a cream. Bod is finalising the import of these bases for development into products for sale in the Australian market. Bod will also develop other skincare products using Nioskin targeting the sensitive skin and elite sports market.

Therapeutic Extracts
With recent changes in the market, Bod is expecting to submit an application for an import licence for a finished good in the form of a therapeutic oil extract containing a standardised GMP manufactured extract.

Bod Australia executives have returned from meeting Linnea representatives at the company’s headquarters in Switzerland following the signing of a Letter of Intent by the two companies announced last month. Linnea’s representatives will visit Australia in June during which time they will meet with Government officials, the investor community and key stakeholders in Bod’s commercialisation plans.

Anyone here know when in June they are coming and anyone involved in the meeting process?

Expand

would love to meet managmeent if they come to sydney, i hold quite a bit still after more at 18.5 if possible

BDA Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 49 more messages in this thread...

First 7 Last

Add BDA (ASX) to my watchlist

would love to meet managmeent if they come to sydney, i hold...

Top Stories

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Resolute shares bounce back as second payment made to Mali government to secure workers' release

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher